The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis.

Yiting ChenNan ShiXin LeiPingping RenLan LanLiangliang ChenYaomin WangYing XuYuxin LinJianghua ChenFei Han

Published in: Rheumatology (Oxford, England) (2023)

Rituximab followed by belimumab or telitacicept may be effective in inducing remission in refractory lupus nephritis, with tolerable adverse effects.

Keyphrases